Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Article  CAS  PubMed  Google Scholar 

Kastrinos F, Kupfer SS, Gupta S. Colorectal Cancer Risk Assessment and Precision approaches to Screening: Brave New World or worlds apart? Gastroenterology. 2023;164(5):812–27. https://doi.org/10.1053/j.gastro.2023.02.021.

Article  PubMed  Google Scholar 

Bond MJG, Bolhuis K, Loosveld OJL, de Groot JWB, Droogendijk H, Helgason HH, et al. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group. Lancet Oncol. 2023;24(7):757–71. https://doi.org/10.1016/s1470-2045(23)00219-x.

Article  CAS  PubMed  Google Scholar 

Luo L, Xu M, Du M, Kou H, Liao D, Cheng Z, et al. Early coagulation tests predict risk stratification and prognosis of COVID-19. Aging. 2020;12(16):15918–37. https://doi.org/10.18632/aging.103581.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yeoh KG, Ho KY, Chiu HM, Zhu F, Ching JY, Wu DC, et al. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60(9):1236–41. https://doi.org/10.1136/gut.2010.221168.

Article  PubMed  Google Scholar 

Niu F, Wen J, Fu X, Li C, Zhao R, Wu S, et al. Stool DNA Test of Methylated Syndecan-2 for the early detection of colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2017;26(9):1411–9. https://doi.org/10.1158/1055-9965.Epi-17-0153.

Article  CAS  PubMed  Google Scholar 

Zhao S, Wang S, Pan P, Xia T, Wang R, Cai Q, et al. FIT-based risk-stratification model effectively screens colorectal neoplasia and early-onset colorectal cancer in Chinese population: a nationwide multicenter prospective study. J Hematol Oncol. 2022;15(1):162doi. https://doi.org/10.1186/s13045-022-01378-1.

Article  CAS  Google Scholar 

Katipally RR, Martinez CA, Pugh SA, Bridgewater JA, Primrose JN, Domingo E, et al. Integrated Clinical-Molecular classification of Colorectal Liver metastases: a biomarker analysis of the phase 3 New EPOC Randomized Clinical Trial. JAMA Oncol. 2023;9(9):1245–54. https://doi.org/10.1001/jamaoncol.2023.2535.

Article  PubMed  Google Scholar 

Mo S, Ye L, Wang D, Han L, Zhou S, Wang H, et al. Early detection of molecular residual disease and risk stratification for stage I to III colorectal Cancer via circulating tumor DNA methylation. JAMA Oncol. 2023;9(6):770–8. https://doi.org/10.1001/jamaoncol.

Article  PubMed  PubMed Central  Google Scholar 

Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for Colorectal Cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021;325(19):1978–98. https://doi.org/10.1001/jama.2021.4417.

Article  PubMed  Google Scholar 

Li S, Han T. Frequent loss of FAM126A expression in colorectal cancer results in selective FAM126B dependency. iScience. 2024;27(5):109646. https://doi.org/10.1016/j.isci.2024.109646.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pagani G. Paolo Gandellini. Cleavage and polyadenylation machinery as a novel targetable vulnerability for human cancer. Cancer Gene Ther. 2024. https://doi.org/10.1038/s41417-024-00770-y.

Article  PubMed  Google Scholar 

Chang Liu Z-Y, Yuan X-X, Zhang J-J, Chang Y, Yang S-J. Novel molecular classification and prognosis of papillary renal cell carcinoma based on a large-scale CRISPR-Cas9 screening and machine learning. Heliyon. 2023;10(1):e23184. https://doi.org/10.1016/j.heliyon.2023.e23184.

Article  CAS  PubMed  Google Scholar 

Malay K, Sannigrahi AC, Cao P, Rajagopalan L, Sun, Robert M, Brody L, Raghav, et al. A novel pipeline for prioritizing cancer type-specific therapeutic vulnerabilities using DepMap identifies PAK2 as a target in head and neck squamous cell carcinomas. Mol Oncol. 2024;18(2):336–49. https://doi.org/10.1002/1878-0261.

Article  Google Scholar 

Marcell, Baranyi et al. László Buday, Balázs Hegedűs,. K-Ras prenylation as a potential anticancer target. Cancer Metastasis Rev. 2020;39(4):1127–1141. https://doi.org/10.1007/s10555-020-09902-w.

Reece Foy K, Xin Lew, Adrian T, Saurin. The search for CDK4/6 inhibitor biomarkers has been hampered by inappropriate proliferation assays. NPJ Breast Cancer. 2024;10(1):19. https://doi.org/10.1038/s41523-024-00624-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ono K, Eguchi T. Large-scale databases and portals on Cancer Genome to analyze chaperone genes correlated to patient prognosis. Methods Mol Biol. 2023;2693:293–306. https://doi.org/10.1007/978-1-0716-3342-7_22.

Article  CAS  PubMed  Google Scholar 

Chetverina D, Vorobyeva NE, Gyorffy B, Shtil AA, Erokhin M. Analyses of Genes Critical to Tumor Survival Reveal Potential ‘Supertargets’: Focus on Transcription. Cancers (Basel). 2023;15(11). https://doi.org/10.3390/cancers15113042.

Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10(5):e1001453. https://doi.org/10.1371/journal.pmed.1001453.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. Gastroenterology. 2010;138(3):958–68. https://doi.org/10.1053/j.gastro.2009.11.005.

Article  CAS  PubMed  Google Scholar 

Szeglin BC, Wu C, Marco MR, Park HS, Zhang Z, Zhang B, et al. A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer. Cancer Rep (Hoboken). 2022;5(1):e1423. https://doi.org/10.1002/cnr2.1423.

Article  CAS  PubMed  Google Scholar 

Vazquez F, Boehm JS. The Cancer Dependency Map enables drug mechanism-of-action investigations. Mol Syst Biol. 2020;16(7):e9757. https://doi.org/10.15252/msb.20209757.

Article  PubMed  PubMed Central  Google Scholar 

Yang C, Zhang H, Chen M, Wang S, Qian R, Zhang L, et al. A survey of optimal strategy for signature-based drug repositioning and an application to liver cancer. Elife. 2022;11. https://doi.org/10.7554/eLife.71880.

Schmidt TJN, Berarducci B, Konstantinidou S, Raffa V. CRISPR-Cas9 in the era of nanomedicine and synthetic biology. Drug Discov Today. 2023;28(1):103375doi. https://doi.org/10.1016/j.drudis.2022.103375.

Article  CAS  Google Scholar 

Wang L, Fu D, Weng S, Xu H, Liu L, Guo C, et al. Genome-scale CRISPR-Cas9 screening stratifies pancreatic cancer with distinct outcomes and immunotherapeutic efficacy. Cell Signal. 2023;110:110811. https://doi.org/10.1016/j.cellsig.2023.110811.

Article  CAS  PubMed  Google Scholar 

Yangyang Zhou S, Wang W, Wu J, Ling H, Li Q, Jia et al. Sustained activation of EGFR-ERK1/2 signaling limits the response to tigecycline-induced mitochondrial respiratory deficiency in liver cancer. EBioMedicine 2023 Jan:87:104397. https://doi.org/10.1016/j.ebiom.2022.104397.

Ouyang Q, Liu Y, Tan J, Li J, Yang D, Zeng F, et al. Loss of ZNF587B and SULF1 contributed to cisplatin resistance in ovarian cancer cell lines based on genome-scale CRISPR-Cas9 screening. Am J Cancer Res. 2019;9(5):988–98.

CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Wang Z, Qin Y. CRISPR-Cas9 system: recent applications in immuno-oncology and cancer immunotherapy. Exp Hematol Oncol. 2023;12(1):95doi. https://doi.org/10.1186/s40164-023-00457-4.

Article  CAS  Google Scholar 

Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222–36. https://doi.org/10.1016/j.tips.2023.01.003.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matthews LA, Guarné A. Dbf4: the whole is greater than the sum of its parts. Cell Cycle. 2013;12(8):1180–8. https://doi.org/10.4161/cc.24416.